Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines: Active Controlled, Double-blind, Randomized, Multi-center, Phase II/III Clinical Trial

Status

UNKNOWN

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02882893

Enrollment

238

Registered

2016-08-30

Start date

2016-08-31

Completion date

2017-04-30

Last updated

2016-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crows Feet Lines

Brief summary

The purpose of this study is to evaluate the Efficacy and Safety of DWP450 treatment of Crows Feet Lines(CFL).

Interventions

DRUGClostridium Botulinum A Toxin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Male or female of at least 18 to 75 years old * Bilaterally symmetrical moderate-to-severe CFL at maximum smile on the FWS as rated by the investigator

Design outcomes

Primary

Measure	Time frame
Facial Wrinkle Scale(FWS) severity of Crow's feet lines(CFL) at maximum smile as assessed by investigators	At 4 weeks

Countries

South Korea

Contacts

Primary ContactDaewoong Clinical

8225508800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026